Read the reviews
Reviews
«Zusammenfassend ist das Buch absolut 'up to date', füllt ein wissenschaftlich und klinisch hoch relevantes 'Nischenthema', und ist im Hinblick auf wissenschaftliche, wie auch direkt klinisch relevante Aspekte sehr ausgewogen.
Es richtet sich als umfassendes 'Übersichtswerk' einerseits an Wissenschaftler der biomedizinischen Wissenschaften, die mit diesem interdisziplinären Themenkomplex betraut sind. Zudem ist es eine wertvolle, interdisziplinäre Informationsquelle für den Kardiologen, allgemeinen Internisten, Infektiologen und Medizinischen Mikrobiologen und Infektionsepidemiologen. Da pharmakologischen Aspekten in vielen Kapiteln ebenfalls eine zentrale Bedeutung zukommt, hat dieses Buch auch einen hohen Wert für die Pharmakologie. Ferner: Bei der exzellenten Aufmachung das Buch enthält sogar mehr als zehn, didaktisch gut ausgewählte Farbabbildungen kann dieses Buch neben seiner hohen Aktualität und Relevanz auch vom Preis-Leistungsverhältnis her wirklich dem oben skizzierten Leserkreis nur empfohlen werden!»
A. Schmidt, Witten/Herdecke (Der Mikrobiologe, Vol. 14, No. 3 (Juni 2004)
... This book presents a comprehensive summary of the most recent cardiovascular and metabolic complications and its treatment implications at press time, making it a useful but not exhaustive resource for HIV specialists, primary care clinicians, cardiologists, house-staff, or students who are not totally familiar with the current literature. The Editor assembled an international group of basic scientists and experienced cardiac, pulmonary and HIV physicians to provide an easily readable update and a broad perspective of these disorders .... Each chapter is nicely referenced and many have concise tables or figures summarizing the available data or postulated mechanisms for these potential complications. The authors appropriately cite the major guideline statements (e.g., Joint National Committee for Detection and Management of Hypertension, the National Cholesterol Education Program) and provide the Framingham risk scores/calculator for assessing cardiovascular risk.
Considering the rapidly evolving state of HIV care and the difficulty with any textbook providing the most up-to-date information due to the lag time from press to publication, the authors have done an excellent job ensuring that the information presented is as current as possible
.. Overall, the composite of up-to-date diagnostic, therapeutic, and preventive information from an international group of experts provides clinicians a quick and useful resource on HAART-related cardiovascular and metabolic complications.
Betty J. Dong, Professor of Clinical Pharmacy
School of Pharmacy, University of California
National HIV/AIDS Clinicians' Consultation Center
San Francisco, California
The Annals of Pharmacotherapy, Vol. 38 (April 2004)
A comprehensive analysis of the most recent findings
Past studies revealed that HIV infection may implicate diverse cardiac diseases such as cardiomyopathy, coronary heart disease, cardiac neoplasms, endocarditis or pericarditis. In addition, it was found that highly active antiretroviral therapy (HAART) often causes - as an adverse effect - a metabolic syndrome characterized by lipodystrophy/lipoatrophy, dyslipidemia and insulin resistance, leading to an increase in coronary artery disease and stroke.
This book focuses on the most recent findings in HIV-associated heart disease and HAART-associated metabolic and cardiovascular complications. In a first part, the epidemiology, pathogenesis and molecular biology of HIV-associated cardiovascular disease, pulmonary hypertension, lipodystrophy and HAART-associated metabolic syndrome are reviewed. The second part offers clinical and therapeutic insights into HIV/HAART-associated atherosclerosis, coronary heart disease, stroke, vasculitic syndromes, and pulmonary hypertension. Besides, cardiovascular complications in HIV-infected children, cardiac surgery in HIV-infected patients, and the prevention and management of HAART-associated cardiovascular complications are points under discussion. Finally, the interaction between HAART and drugs commonly used to treat cardiovascular disease is carefully analyzed.
HIV Infection and the Cardiovascular System presents state-of-the-art findings of basic and clinical scientists and is a valuable reference for specialists in cardiology and internal medicine as well as for infectiologists.
Log in to MyKarger to check if you already have access to this title.